AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19110026 — Biomarker: BDNF mRNA
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: BDNF
Study 19110026 — Biomarker: BDNF
Type: Safety Biomarker (SAF)
Study 29114907 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 27296360 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27325795 — Biomarker: Serum calcium
Type: Surrogate Endpoint (SUR)
Study 25294886 — Biomarker: KRAS mRNA
Type: Predictive Biomarker (PRD)
Genes: KRAS; KRAS2; RASK2
Study 17826777 — Biomarker: TBXT mRNA
Type: Predictive Biomarker (PRD)
Genes: TBXT; T
Study 25680887 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25680887 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 28351060 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8287317 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 25079365 — Biomarker: Interleukin 1
Type: Safety Biomarker (SAF)
Study 25079365 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 21710402 — Biomarker: SST mRNA
Type: Predictive Biomarker (PRD)
Genes: SST
Study 21710402 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15144688 — Biomarker: Biliary glycoprotein 1
Type: Safety Biomarker (SAF)
Genes: CEACAM1; BGP; BGP1
Study 15144688 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 8401150 — Biomarker: ENG mRNA
Type: Predictive Biomarker (PRD)
Genes: ENG; END
Study 30921804 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 16504691 — Biomarker: Interleukin 18
Type: Safety Biomarker (SAF)
Genes: IL18; IGIF; IL1F4
Study 9313603 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8383396 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3536151 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 19086814 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 7503087 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 7503087 — Biomarker: Serum alkaline phosphatase
Type: Surrogate Endpoint (SUR)
Study 30117365 — Biomarker: Cytochrome c
Type: Safety Biomarker (SAF)
Study 25138127 — Biomarker: SP6 mRNA
Type: Predictive Biomarker (PRD)
Genes: SP6; KLF14
Study 19783715 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2666249 — Biomarker: SMS mRNA
Type: Predictive Biomarker (PRD)
Genes: SMS
Study 20143531 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 14967062 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 1833301 — Biomarker: PBX1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PBX1; PRL
Study 1833301 — Biomarker: TRH mRNA
Type: Predictive Biomarker (PRD)
Genes: TRH
Study 1833301 — Biomarker: Thyroid stimulating hormone
Type: Safety Biomarker (SAF)
Study 28174353 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 24293094 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 22854880 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 22854880 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 18634706 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 18634706 — Biomarker: Intercellular adhesion molecule 1
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: ICAM1
Study 18634706 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17961422 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 9824387 — Biomarker: AHR mRNA
Type: Predictive Biomarker (PRD)
Genes: AHR; BHLHE76
Study 23666460 — Biomarker: Cardiac troponin I
Type: Safety Biomarker (SAF)
Genes: TNNI3; TNNC1
Study 21857144 — Biomarker: SLC6A3
Type: Safety Biomarker (SAF)
Genes: DAT
Study 28838263 — Biomarker: GSTK1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GSTK1; HDCMD47P
Study 28838263 — Biomarker: GSTM1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GSTM1; GST1
Study 28838263 — Biomarker: CYP1B1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP1B1
Study 28838263 — Biomarker: CYP2E1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP2E1; CYP2E
Study 18823395 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 12563567 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2643865 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27358638 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 27358638 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 27358638 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 27358638 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 27358638 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 7662752 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 7662752 — Biomarker: GSR mRNA
Type: Predictive Biomarker (PRD)
Genes: GSR; GLUR; GRD1
Study 19684472 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study 14681846 — Biomarker: Gastric inhibitory polypeptide
Type: Pharmacodynamic Biomarker (PDY)
Genes: GIP
Study 9833177 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16505046 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15599834 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 9062618 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29266290 — Biomarker: Metalloproteinase inhibitor 1
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: TIMP1; CLGI; TIMP
Study 29266290 — Biomarker: Hepatocyte growth factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: HGF; HPTA
Study 27130705 — Biomarker: B-type natriuretic peptide
Type: Safety Biomarker (SAF)
Genes: NPPB
Study 24012684 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23406818 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1324011 — Biomarker: POMC
Type: Predictive Biomarker (PRD)
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 6734705 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 30957673 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 22891782 — Biomarker: Mitochondrial DNA
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 22891782 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 22891782 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 25803626 — Biomarker: FOS mRNA
Type: Predictive Biomarker (PRD)
Genes: FOS; G0S7
Study 19784816 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 15198784 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study 11465516 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 25528430 — Biomarker: Cholesteryl ester transfer protein
Type: Pharmacodynamic Biomarker (PDY)
Genes: CETP
Study 25528430 — Biomarker: LCAT mRNA
Type: Predictive Biomarker (PRD)
Genes: LCAT
Study 19217460 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 17313292 — Biomarker: GAST mRNA
Type: Predictive Biomarker (PRD)
Genes: GAST; GAS
Study 11593094 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 11593094 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28517955 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 9523210 — Biomarker: BRCA1 mRNA
Type: Predictive Biomarker (PRD)
Genes: BRCA1; RNF53
Study 7907073 — Biomarker: Serum alkaline phosphatase
Type: Surrogate Endpoint (SUR)
Study 29042358 — Biomarker: Adenosine deaminase
Type: Monitoring Biomarker (MOI)
Genes: ADA; ADA1
Study 22445501 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 22445501 — Biomarker: Interleukin 1
Type: Safety Biomarker (SAF)
Study 22445501 — Biomarker: IL-6 and IL-10
Type: Safety Biomarker (SAF)
Study 28681387 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 26373676 — Biomarker: MYC mRNA
Type: Predictive Biomarker (PRD)
Genes: MYC; BHLHE39
Study 26373676 — Biomarker: Apoptosis regulator Bcl-2
Type: Predictive Biomarker (PRD)
Genes: BCL2
Study 26373676 — Biomarker: BCL6 mRNA
Type: Predictive Biomarker (PRD)
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study 28864749 — Biomarker: CYP3A5 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A5
Study 28864749 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 16322487 — Biomarker: AMPH mRNA
Type: Predictive Biomarker (PRD)
Genes: AMPH; AMPH1
Study 23277897 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 21593294 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19879995 — Biomarker: MPL mRNA
Type: Predictive Biomarker (PRD)
Genes: MPL; TPOR
Study 15521842 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 9331018 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6383654 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 26817502 — Biomarker: CD28 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD28
Study 26817502 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23257132 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23257132 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 10432323 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 27785095 — Biomarker: von Willebrand factor
Type: Safety Biomarker (SAF)
Genes: VWF; F8VWF
Study 27785095 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9728898 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 12370851 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 12370851 — Biomarker: LCAT mRNA
Type: Predictive Biomarker (PRD)
Genes: LCAT
Study 12370851 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 2509069 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 31898756 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 26474452 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 18785308 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 7028935 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24836310 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 18270675 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3537872 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 26797718 — Biomarker: Vitamin B12
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 24882370 — Biomarker: Carcinoembryonic antigen CEA
Type: Monitoring Biomarker (MOI)
Genes: CEACAM5; CEA
Study 9709470 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 17764549 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8138400 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 25609853 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 25609853 — Biomarker: Lactate dehydrogenase
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 17924971 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 15207897 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 9510003 — Biomarker: MCAT mRNA
Type: Predictive Biomarker (PRD)
Genes: MCAT; MT
Study 2466454 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28285280 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26081658 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 24307311 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 24307311 — Biomarker: Matrix metalloproteinase 9
Type: Pharmacodynamic Biomarker (PDY)
Genes: MMP9; CLG4B
Study 21876349 — Biomarker: C-C motif chemokine 2
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CCL2; MCP1; SCYA2
Study 19236643 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8239010 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3010028 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 3010028 — Biomarker: Serum triglycerides
Type: Surrogate Endpoint (SUR)
Study 30766555 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22729798 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15672306 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7717488 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24379596 — Biomarker: CBLIF mRNA
Type: Predictive Biomarker (PRD)
Genes: CBLIF; GIF; IFMH
Study 15199619 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 15199619 — Biomarker: Mitochondrial DNA
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 2494014 — Biomarker: LCT mRNA
Type: Predictive Biomarker (PRD)
Genes: LCT; LPH
Study 23428878 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 23428878 — Biomarker: IL-6 and IL-10
Type: Safety Biomarker (SAF)
Study 20840349 — Biomarker: ACR mRNA
Type: Predictive Biomarker (PRD)
Genes: ACR; ACRS
Study 17320026 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 15311423 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3306292 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 31365441 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19661957 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 19661957 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 1346268 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22264996 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 22264996 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 18381581 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 20304772 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 22801271 — Biomarker: OAT mRNA
Type: Predictive Biomarker (PRD)
Genes: OAT
Study 25688817 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 25688817 — Biomarker: C-C motif chemokine 2
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CCL2; MCP1; SCYA2
Study 24047421 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 20007081 — Biomarker: Myeloperoxidase
Type: Safety Biomarker (SAF)
Genes: MPO
Study 2373126 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28452603 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24731832 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17426744 — Biomarker: CGA mRNA
Type: Predictive Biomarker (PRD)
Genes: CGA
Study 17426744 — Biomarker: GLS2 mRNA
Type: Predictive Biomarker (PRD)
Genes: GLS2; GA
Study 17426744 — Biomarker: TMPRSS11A mRNA
Type: Predictive Biomarker (PRD)
Genes: TMPRSS11A; ECRG1; HATL1; HESP
Study 17426744 — Biomarker: CPSF4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CPSF4; CPSF30; NAR; NEB1
Study 17426744 — Biomarker: ENG mRNA
Type: Predictive Biomarker (PRD)
Genes: ENG; END
Study 15837829 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 15837829 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6794419 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27589225 — Biomarker: CD34 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD34
Study 14508230 — Biomarker: Natriuretic peptides A
Type: Safety Biomarker (SAF)
Genes: NPPA; ANP; PND
Study 14508230 — Biomarker: B-type natriuretic peptide
Type: Safety Biomarker (SAF)
Genes: NPPB
Study 14621737 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 15981669 — Biomarker: Intact parathyroid hormone
Type: Predictive Biomarker (PRD)
Study 12589351 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 10475285 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30659666 — Biomarker: Interleukin 10
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL10
Study 30659666 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 30659666 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 30659666 — Biomarker: Osteopontin
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: SPP1; BNSP; OPN; PSEC0156
Study 30659666 — Biomarker: TNFRSF11B mRNA
Type: Predictive Biomarker (PRD)
Genes: TNFRSF11B; OCIF; OPG
Study 27331913 — Biomarker: KL mRNA
Type: Predictive Biomarker (PRD)
Genes: KL
Study 27331913 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 27331913 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21061756 — Biomarker: MAL mRNA
Type: Predictive Biomarker (PRD)
Genes: MAL
Study 9580313 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 9580313 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 27426936 — Biomarker: MVD mRNA
Type: Predictive Biomarker (PRD)
Genes: MVD; MPD
Study 26630576 — Biomarker: PIK3CA mRNA
Type: Predictive Biomarker (PRD)
Genes: PIK3CA
Study 26630576 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 26630576 — Biomarker: PDGFRA mRNA
Type: Predictive Biomarker (PRD)
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 26630576 — Biomarker: Tyrosine-protein kinase ABL1
Type: Pharmacodynamic Biomarker (PDY)
Genes: ABL1; ABL; JTK7
Study 26630576 — Biomarker: Proto-oncogene c-Met
Type: Predictive Biomarker (PRD)
Genes: MET
Study 26630576 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 30222861 — Biomarker: AMT mRNA
Type: Predictive Biomarker (PRD)
Genes: AMT; GCST
Study 30222861 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2553879 — Biomarker: MVP mRNA
Type: Predictive Biomarker (PRD)
Genes: MVP; LRP
Study 2553879 — Biomarker: CAMP mRNA
Type: Predictive Biomarker (PRD)
Genes: CAMP; CAP18; FALL39; HSD26
Study 31550354 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 19427269 — Biomarker: Peripheral myelin protein 22
Type: Pharmacodynamic Biomarker (PDY)
Genes: PMP22; GAS3
Study 11185653 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 31535829 — Biomarker: SLC5A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC5A2; SGLT2
Study 14523778 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 24342681 — Biomarker: Aminopeptidase N
Type: Safety Biomarker (SAF)
Genes: ANPEP; APN; CD13; PEPN
Study 22389919 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 20390409 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 16108943 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 24602919 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 16702331 — Biomarker: TTR mRNA
Type: Predictive Biomarker (PRD)
Genes: TTR; PALB
Study 11234265 — Biomarker: ID1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ID1; BHLHB24; ID
Study 20069390 — Biomarker: von Willebrand factor
Type: Safety Biomarker (SAF)
Genes: VWF; F8VWF
Study 15930445 — Biomarker: CCK mRNA
Type: Predictive Biomarker (PRD)
Genes: CCK
Study 1693740 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25683704 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 25683704 — Biomarker: Serum LDL cholesterol
Type: Surrogate Endpoint (SUR)
Study 19522983 — Biomarker: Matrix metalloproteinase 1
Type: Monitoring Biomarker (MOI)
Genes: MMP1; CLG
Study 9172913 — Biomarker: Argininosuccinate synthase
Type: Safety Biomarker (SAF)
Genes: ASS1; ASS
Study 29614993 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29614993 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 30286768 — Biomarker: AMH mRNA
Type: Predictive Biomarker (PRD)
Genes: AMH; MIF
Study 14962813 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 2928998 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16204787 — Biomarker: Eosinophil cationic protein
Type: Safety Biomarker (SAF)
Genes: RNASE3; ECP; RNS3
Study 23975842 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24408124 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 24408124 — Biomarker: Interleukin 13
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: IL13; NC30
Study 10381298 — Biomarker: FCGR3B
Type: Predictive Biomarker (PRD)
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 10381298 — Biomarker: CD14 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD14